Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Acquisition cost for antibacterials major cost driver

    • 7 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Acquisition cost for antibacterials major cost driver. Pharmacoecon. Outcomes News 234, 7 (1999). https://doi.org/10.1007/BF03275195

    Download citation

    Keywords

    • Neutropenia
    • Gentamicin
    • Febrile Neutropenia
    • Acquisition Cost
    • Piperacillin